DZD-0095

N/A

Report date: 2022/01/13 17:57:38
NME

Base Information

Drug NameDZD-0095
Drug Alias NameDZD-0095
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonocarboxylate transporter 4 inhibitors
TargetsMonocarboxylate transporter 4
Therapy Area/IndicationsSolid tumoursLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A